Quality bowel preparation for surveillance colonoscopy in patients with inflammatory bowel disease is a must

Gastrointestinal Endoscopy Clinics of North America

Volumn 24, Issue 3, 2014, Pages 379-392

  Nett, Andrew ^a   Velayos, Fernando ^a   McQuaid, Kenneth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bowel preparation; Dysplasia surveillance; Inflammatory bowel disease

Indexed keywords

LAXATIVE;

ASPIRATION; CANCER DIAGNOSIS; COLITIS; COLONOSCOPY; DIARRHEA; DIET RESTRICTION; DISEASE ACTIVITY; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG DOSE REGIMEN; DYSPLASIA; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE PREPARATION; MEDICAL LITERATURE; META ANALYSIS (TOPIC); PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STOMACH DISEASE; STOMACH RETENTION; SURVEILLANCE COLONOSCOPY; SYSTEMATIC REVIEW; COLORECTAL NEOPLASMS; COMPLICATION; DIAGNOSTIC USE; EARLY DIAGNOSIS; PATHOLOGY; PRECANCEROUS CONDITIONS; PROCEDURES;

CATHARTICS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; INFLAMMATORY BOWEL DISEASES; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PRECANCEROUS CONDITIONS;

EID: 84903437515     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2014.03.004     Document Type: Review

References (56)

1. Delaunoit T., Limburg P.J., Goldberg R.M., et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006, 4(3):335-342.
2. Greenstein A.J., Slater G., Heimann T.M., et al. Acomparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg 1986, 203(2):123-128.
3. Watanabe T., Konishi T., Kishimoto J., et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis 2011, 17(3):802-808.
4. Ording A.G., Horvath-Puho E., Erichsen R., et al. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study. Inflamm Bowel Dis 2013, 19(4):800-805.
5. Wang Y.R., Cangemi J.R., Loftus E.V., et al. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol 2013, 108(3):444-449.
6. Lutgens M.W., Oldenburg B., Siersema P.D., et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 2009, 101(10):1671-1675.
7. Karlen P., Kornfeld D., Brostrom O., et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998, 42(5):711-714.
8. Collins P.D. Strategies for detecting colon cancer and dysplasia in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013, 19(4):860-863.
9. Farraye F.A., Odze R.D., Eaden J., et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010, 138(2):738-745.
10. Kornbluth A., Sachar D.B., Practice Parameters Committee of the American College of Gastroenterology Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010, 105(3):501-523. [quiz: 524].
11. Leighton J.A., Shen B., Baron T.H., et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc 2006, 63(4):558-565.
12. Cairns S.R., Scholefield J.H., Steele R.J., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59(5):666-689.
13. Soetikno R., Subramanian V., Kaltenbach T., et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 2013, 144(7):1349-1352. 1352.e1-6.
14. Clinical practice guidelines for surveillance colonoscopy-in adenoma follow-up; following curative resection of colorectal cancer; and for cancer surveillance in inflammatory bowel disease. Cancer Council Australia (December 2011).
15. Van Assche G., Dignass A., Bokemeyer B., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. JCrohns Colitis 2013, 7(1):1-33.
16. Harewood G.C., Sharma V.K., de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc 2003, 58(1):76-79.
17. Lebwohl B., Kastrinos F., Glick M., et al. The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc 2011, 73(6):1207-1214.
18. Rex D.K., Imperiale T.F., Latinovich D.R., et al. Impact of bowel preparation on efficiency and cost of colonoscopy. Am J Gastroenterol 2002, 97(7):1696-1700.
19. Froehlich F., Wietlisbach V., Gonvers J.J., et al. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: The European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc 2005, 61(3):378-384.
20. Parra-Blanco A., Nicolas-Perez D., Gimeno-Garcia A., et al. The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: a randomized study. World J Gastroenterol 2006, 12(38):6161-6166.
21. Chokshi R.V., Hovis C.E., Hollander T., et al. Prevalence of missed adenomas in patients with inadequate bowel preparation on screening colonoscopy. Gastrointest Endosc 2012, 75(6):1197-1203.
22. Sagi S.V., Guturu P., Gottumukkala R.S. Missed adenomas in patients with inadequate bowel preparation. Gastrointest Endosc 2012, 76(3):705.
23. Toruner M., Harewood G.C., Loftus E.V., et al. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease. Inflamm Bowel Dis 2005, 11(5):428-434.
24. Kiesslich R., Neurath M.F. Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight. Gut 2004, 53(2):165-167.
25. Romero R.V., Mahadeva S. Factors influencing quality of bowel preparation for colonoscopy. World J Gastrointest Endosc 2013, 5(2):39-46.
26. Nguyen D.L., Wieland M. Risk factors predictive of poor quality preparation during average risk colonoscopy screening: the importance of health literacy. JGastrointestin Liver Dis 2010, 19(4):369-372.
27. Chan W.K., Saravanan A., Manikam J., et al. Appointment waiting times and education level influence the quality of bowel preparation in adult patients undergoing colonoscopy. BMC Gastroenterol 2011, 11:86.
28. Bessissow T., Van Keerberghen C.A., Van Oudenhove L., et al. Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls. JCrohns Colitis 2013, 7(11):e580-e587.
29. Lim S.W., Seo Y.W., Sinn D.H., et al. Impact of previous gastric or colonic resection on polyethylene glycol bowel preparation for colonoscopy. Surg Endosc 2012, 26(6):1554-1559.
30. Chung Y.W., Han D.S., Park K.H., et al. Patient factors predictive of inadequate bowel preparation using polyethylene glycol: a prospective study in Korea. JClin Gastroenterol 2009, 43(5):448-452.
31. Denters M.J., Schreuder M., Depla A.C., et al. Patients' perception of colonoscopy: patients with inflammatory bowel disease and irritable bowel syndrome experience the largest burden. Eur J Gastroenterol Hepatol 2013, 25(8):964-972.
32. Friedman S., Cheifetz A.S., Farraye F.A., et al. Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013, 19(3):534-539.
33. Connor A., Tolan D., Hughes S., et al. Consensus guidelines for the safe prescription and administration of oral bowel-cleansing agents. Gut 2012, 61(11):1525-1532.
34. Sipe B.W., Fischer M., Baluyut A.R., et al. Alow-residue diet improved patient satisfaction with split-dose oral sulfate solution without impairing colonic preparation. Gastrointest Endosc 2013, 77(6):932-936.
35. Soweid A.M., Kobeissy A.A., Jamali F.R., et al. Arandomized single-blind trial of standard diet versus fiber-free diet with polyethylene glycol electrolyte solution for colonoscopy preparation. Endoscopy 2010, 42(8):633-638.
36. Park D.I., Park S.H., Lee S.K., et al. Efficacy of prepackaged, low residual test meals with 4L polyethylene glycol versus a clear liquid diet with 4L polyethylene glycol bowel preparation: a randomized trial. JGastroenterol Hepatol 2009, 24(6):988-991.
37. Delegge M., Kaplan R. Efficacy of bowel preparation with the use of a prepackaged, low fibre diet with a low sodium, magnesium citrate cathartic vs. a clear liquid diet with a standard sodium phosphate cathartic. Aliment Pharmacol Ther 2005, 21(12):1491-1495.
38. Kilgore T.W., Abdinoor A.A., Szary N.M., et al. Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials. Gastrointest Endosc 2011, 73(6):1240-1245.
39. Enestvedt B.K., Tofani C., Laine L.A., et al. 4-liter split-dose polyethylene glycol is superior to other bowel preparations, based on systematic review and meta-analysis. Clin Gastroenterol Hepatol 2012, 10(11):1225-1231.
40. Gurudu S.R., Ramirez F.C., Harrison M.E., et al. Increased adenoma detection rate with system-wide implementation of a split-dose preparation for colonoscopy. Gastrointest Endosc 2012, 76(3):603-608.e1.
41. Rex D.K., Johnson D.A., Anderson J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009, 104(3):739-750.
42. Wexner S.D., Beck D.E., Baron T.H., et al. Aconsensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc 2006, 63(7):894-909.
43. Unger R.Z., Amstutz S.P., Seo da H., et al. Willingness to undergo split-dose bowel preparation for colonoscopy and compliance with split-dose instructions. Dig Dis Sci 2010, 55(7):2030-2034.
44. Khan M.A., Piotrowski Z., Brown M.D. Patient acceptance, convenience, and efficacy of single-dose versus split-dose colonoscopy bowel preparation. JClin Gastroenterol 2010, 44(4):310-311.
45. Park S.S., Sinn D.H., Kim Y.H., et al. Efficacy and tolerability of split-dose magnesium citrate: low-volume (2 liters) polyethylene glycol vs. single- or split-dose polyethylene glycol bowel preparation for morning colonoscopy. Am J Gastroenterol 2010, 105(6):1319-1326.
46. American Society of Anesthesiologists Committee Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists committee on standards and practice parameters. Anesthesiology 2011, 114(3):495-511.
47. Huffman M., Unger R.Z., Thatikonda C., et al. Split-dose bowel preparation for colonoscopy and residual gastric fluid volume: an observational study. Gastrointest Endosc 2010, 72(3):516-522.
48. Di Palma J.A., Rodriguez R., McGowan J., et al. Arandomized clinical study evaluating the safety and efficacy of a new, reduced-volume, oral sulfate colon-cleansing preparation for colonoscopy. Am J Gastroenterol 2009, 104(9):2275-2284.
49. Suclear(R) [package insert]. Braintree, MA: Braintree Laboratories; 2013. Available at:. Accessed December 12, 2013. http://www.suclearkit.com/collateral/documents/suclear/SUCLEAR-PI-MedGuide-MARCH-2013.pdf.
50. Markowitz G.S., Stokes M.B., Radhakrishnan J., et al. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. JAm Soc Nephrol 2005, 16(11):3389-3396.
51. Hassan C., Bretthauer M., Kaminski M.F., et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2013, 45(2):142-150.
52. Rosenfeld G., Krygier D., Enns R.A., et al. The impact of patient education on the quality of inpatient bowel preparation for colonoscopy. Can J Gastroenterol 2010, 24(9):543-546.
53. Spiegel B.M., Talley J., Shekelle P., et al. Development and validation of a novel patient educational booklet to enhance colonoscopy preparation. Am J Gastroenterol 2011, 106(5):875-883.
54. Tae J.W., Lee J.C., Hong S.J., et al. Impact of patient education with cartoon visual aids on the quality of bowel preparation for colonoscopy. Gastrointest Endosc 2012, 76(4):804-811.
55. Shaikh A.A., Hussain S.M., Rahn S., et al. Effect of an educational pamphlet on colon cancer screening: a randomized, prospective trial. Eur J Gastroenterol Hepatol 2010, 22(4):444-449.
56. Jung Y.S., Seok H.S., Park D.I., et al. Aclear liquid diet is not mandatory for polyethylene glycol-based bowel preparation for afternoon colonoscopy in healthy outpatients. Gut Liver 2013, 7(6):681-687.